APA (7th ed.) Citation

WYK, C., NW, F., ECH, F., APY, L., CLS, Y., JPW, Y., . . . W, L. (2024). Autologous hematopoietic stem cell transplantation followed by quadruple immunotherapy with dinutuximab beta, sargramostim, aldesleukin, and spironolactone for relapsed metastatic retinoblastoma. Pediatric blood & cancer, 71(7), e31044. https://doi.org/10.1002/pbc.31044

Chicago Style (17th ed.) Citation

WYK, Chan, et al. "Autologous Hematopoietic Stem Cell Transplantation Followed by Quadruple Immunotherapy with Dinutuximab Beta, Sargramostim, Aldesleukin, and Spironolactone for Relapsed Metastatic Retinoblastoma." Pediatric Blood & Cancer 71, no. 7 (2024): e31044. https://doi.org/10.1002/pbc.31044.

MLA (9th ed.) Citation

WYK, Chan, et al. "Autologous Hematopoietic Stem Cell Transplantation Followed by Quadruple Immunotherapy with Dinutuximab Beta, Sargramostim, Aldesleukin, and Spironolactone for Relapsed Metastatic Retinoblastoma." Pediatric Blood & Cancer, vol. 71, no. 7, 2024, p. e31044, https://doi.org/10.1002/pbc.31044.